Search Results - "Loveless, S."

Refine Results
  1. 1

    KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis by Hares, Kelly, Kemp, K., Loveless, S., Rice, C. M., Scolding, N., Tallantyre, E., Robertson, N., Wilkins, A.

    Published in Journal of neurology (01-06-2021)
    “…There is increasing interest in the development of multiple sclerosis (MS) biomarkers that reflect central nervous system tissue injury to determine prognosis…”
    Get full text
    Journal Article
  2. 2

    Fault zone hydrogeology by Bense, V.F., Gleeson, T., Loveless, S.E., Bour, O., Scibek, J.

    Published in Earth-science reviews (01-12-2013)
    “…Deformation along faults in the shallow crust (<1km) introduces permeability heterogeneity and anisotropy, which has an important impact on processes such as…”
    Get full text
    Journal Article
  3. 3

    A method for screening groundwater vulnerability from subsurface hydrocarbon extraction practices by Loveless, S.E., Lewis, M.A., Bloomfield, J.P., Davey, I., Ward, R.S., Hart, A., Stuart, M.E.

    Published in Journal of environmental management (01-11-2019)
    “…This paper describes a new screening method for assessing groundwater vulnerability to pollution from hydrocarbon exploitation in the subsurface. The method…”
    Get full text
    Journal Article
  4. 4

    Pharmacologic Therapies in Musculoskeletal Conditions by Loveless, Melinda S., MD, Fry, Adrielle L., MD

    Published in The Medical clinics of North America (01-07-2016)
    “…Musculoskeletal conditions are common, and there are many options for pharmacologic therapy. Unfortunately, there is not strong evidence for the use of many of…”
    Get full text
    Journal Article
  5. 5

    Systemic complement profiling in multiple sclerosis as a biomarker of disease state by Ingram, G, Hakobyan, S, Hirst, CL, Harris, CL, Loveless, S, Mitchell, JP, Pickersgill, TP, Robertson, NP, Morgan, BP

    Published in Multiple sclerosis (01-10-2012)
    “…Background: There is increasing evidence of significant and dynamic systemic activation and upregulation of complement in multiple sclerosis (MS), which may…”
    Get full text
    Journal Article
  6. 6

    Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity by Ingram, G., Bugert, J. J., Loveless, S., Robertson, N. P.

    Published in European journal of neurology (01-11-2010)
    “…Background:  Sero‐epidemiological studies have demonstrated the association between multiple sclerosis (MS) and prior Epstein–Barr virus (EBV) infection. It…”
    Get full text
    Journal Article
  7. 7

    Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies by Beesley, R., Cauchi, M., Davies, L., Upcott, M., Norton, E., Loveless, S., Anderson, V., Wynford-Thomas, R., Pickersgill, T.P., Uzochukwu, E., Wardle, M., Robertson, N.P., Tallantyre, E., Willis, M.D.

    Published in Multiple sclerosis and related disorders (01-12-2022)
    “…•Isolation behavior associated with age, disability and use of high-efficacy DMTs.•Vulnerability associated with higher EDSS and receiving a high-efficacy…”
    Get full text
    Journal Article
  8. 8

    Potency values from the local lymph node assay: Application to classification, labelling and risk assessment by Loveless, S.E., Api, A.-M., Crevel, R.W.R., Debruyne, E., Gamer, A., Jowsey, I.R., Kern, P., Kimber, I., Lea, L., Lloyd, P., Mehmood, Z., Steiling, W., Veenstra, G., Woolhiser, M., Hennes, C.

    Published in Regulatory toxicology and pharmacology (01-02-2010)
    “…Hundreds of chemicals are contact allergens but there remains a need to identify and characterise accurately skin sensitising hazards. The purpose of this…”
    Get full text
    Journal Article
  9. 9

    Site-specific clinical disease onset in multiple sclerosis by Willis, M. D., Harding, K. E., Wardle, M., Pickersgill, T. P., Tomassini, V., Loveless, S., Robertson, N. P.

    Published in European journal of neurology (01-04-2015)
    “…Background and purpose Multiple sclerosis is a chronic inflammatory disorder of the central nervous system characterized by acute episodes of neurological…”
    Get full text
    Journal Article
  10. 10

    POI19 EBNA-1 IgG is not a reliable clinical marker of multiple sclerosis disease activity by Ingram, G, Bugert, J J, Loveless, S, Robertson, N P

    “…Sero-epidemiological studies have demonstrated association between multiple sclerosis (MS) and prior Epstein–Barr virus (EBV) infection and it has been…”
    Get full text
    Journal Article
  11. 11

    Withholding resuscitation : A new approach to prehospital end-of-life decisions by FEDER, Sylvia, MATHENY, Roger L, LOVELESS, Robert S, REA, Thomas D, KELLERMANN, Arthur, LYNN, Joanne

    Published in Annals of internal medicine (02-05-2006)
    “…Emergency medical services (EMS) personnel often are not permitted to honor requests to withhold resuscitation at the end of life, particularly if there is no…”
    Get full text
    Journal Article
  12. 12

    Nonoperative Management of Acetabular Labral Tear in a Skeletally Immature Figure Skater by Liem, Brian C., MD, Loveless, Melinda S., MD, Apple, Elizabeth L., PT, DPT, Krabak, Brian J., MD, MBA, FACSM

    Published in PM & R (01-10-2014)
    “…Acetabular labral tear is an uncommon cause of hip pain in the skeletally immature athlete. Treatment outcomes have mostly been described in the surgical…”
    Get full text
    Journal Article
  13. 13

    Genetics of species differences in sailfin and shortfin mollies by Loveless, S A, Bridges, Jr, W C, Ptacek, M B

    Published in Heredity (01-10-2010)
    “…Premating reproductive isolation is a strong barrier to hybridization in natural populations, but little is known about the genetic mechanisms that allow…”
    Get full text
    Journal Article
  14. 14

    The local lymph node assay: A viable alternative to currently accepted skin sensitization tests by Basketter, D.A., Gerberick, G.F., Kimber, I., Loveless, S.E.

    Published in Food and chemical toxicology (01-10-1996)
    “…The prospective identification of skin sensitizing chemicals is a vital prerequisite for their proper risk management. Traditionally this has been achieved…”
    Get full text
    Journal Article
  15. 15

    Cytokine mRNA profiles for isocyanates with known and unknown potential to induce respiratory sensitization by Plitnick, L.M., Loveless, S.E., Ladics, G.S., Holsapple, M.P., Smialowicz, R.J., Woolhiser, M.R., Anderson, P.K., Smith, C., Selgrade, M.J.K.

    Published in Toxicology (Amsterdam) (28-02-2005)
    “…Isocyanates are low-molecular-weight chemicals implicated in allergic asthmatic-type reactions. Identification of chemicals likely to cause asthma is difficult…”
    Get full text
    Journal Article
  16. 16

    Cytokine Profiling for Chemical Sensitizers: Application of the Ribonuclease Protection Assay and Effect of Dose by Plitnick, L.M., Loveless, S.E., Ladics, G.S., Holsapple, M.P., Selgrade, M.J., Sailstad, D.M., Smialowicz, R.J.

    Published in Toxicology and applied pharmacology (15-03-2002)
    “…Exposure to chemicals in domestic and occupational settings may contribute to increases in asthma and allergy. Airway hypersensitivity (AHS) is T helper-2…”
    Get full text
    Journal Article
  17. 17

    Production of 15 O for Medical Applications via the 16 O(γ,n) 15 O Reaction by Queern, Stacy L, Cardman, Ryan, Loveless, Christopher S, Shepherd, Matthew R, Lapi, Suzanne E

    Published in Journal of Nuclear Medicine (01-03-2019)
    “…O (half-life, 122 s) is a useful radionuclide for PET applications. Current production of O typically makes use of the N(d,n) O, N(p,n) O, or O(p,pn) O…”
    Get full text
    Journal Article
  18. 18

    Toxicological evaluation of sodium perfluorohexanoate by Loveless, Scott E, Slezak, Brian, Serex, Tessa, Lewis, Joseph, Mukerji, Pushkor, O’Connor, John C, Donner, E. Maria, Frame, Steven R, Korzeniowski, Stephen H, Buck, Robert C

    Published in Toxicology (Amsterdam) (01-10-2009)
    “…Abstract Sodium perfluorohexanoate [NaPFHx, F(CF2 )5 CO2 Na, CAS#2923-26-4] was evaluated in acute, 90-day subchronic, one-generation reproduction,…”
    Get full text
    Journal Article
  19. 19

    Further evaluation of the local lymph node assay in the final phase of an international collaborative trial by Loveless, Scott E., Ladies, Gregory S., Gerberick, G.Frank, Ryan, Cindy A., Basketter, David A., Scholes, Edward W., House, Robert V., Hilton, Jennifer, Dearman, Rebecca J., Kimber, Ian

    Published in Toxicology (Amsterdam) (15-04-1996)
    “…The local lymph node assay (LLNA) is a method used for the prospective identification in mice of chemicals that have the potential to cause skin sensitization…”
    Get full text
    Journal Article
  20. 20

    Manganese-52 production cross-section measurements via irradiation of natural chromium targets up to 20 MeV by El Sayed, Retta, Massicano, Adriana V.F., Queern, Stacy L., Loveless, Christopher S., Lapi, Suzanne E.

    Published in Applied radiation and isotopes (01-05-2019)
    “…Manganese-52g, 54 and Chromium-51 production cross-section measurements were conducted using natural chromium foils and copper monitor foils. Proton beam…”
    Get full text
    Journal Article